OMA Guidelines Bundle

Obesity Nutrition and Activity 2026

Obesity Medicine Association OMA GUIDELINES App Bundle brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1544299

Contents of this Issue

Navigation

Page 12 of 33

13 Intermittent Fasting and Time-Restricted Eating Fasting methods, including alternative-day, intermittent, or time- restricted eating, may facilitate overall caloric restriction and promote weight reduction. The 5:2 Diet: Vitamins, minerals, and f iber supplementation depending on patient requirement. Fasting-Mimicking Diet: An intermittent fasting approach characterized by low-protein, high-fat, and low-calorie intake, using prepackaged meals over f ive days. All meals are plant-based and formulated to deliver 34% to 54% of the standard caloric intake. Should be used in periodic cycles every two weeks to several months and last four to seven days. Alternate-Day Fasting: Alternate-day fasting, which involves alternating between days of regular caloric intake and days of caloric restriction. Time-Restricted Eating: A dietary regimen in which food consumption is conf ined to a designated time-f rame, typically encompassing an 8-hour eating period succeeded by a 16-hour fasting interval. Advantages Disadvantages • Reduced decision fatigue regarding food selection • Quickly reversible • May align more effectively with daily patient scheduling, including during Ramadan • May reduce caloric intake with variable effects on lean body mass, resting metabolic rate, and total energy expenditure, often dependent upon physical activity • May contribute to weight reduction and enhance metabolic parameters, including insulin sensitivity, blood pressure, lipid levels, and inflammatory markers • May be improvements in metabolic dysfunction- associated steatotic liver disease • Risk of malnutrition if the meals eaten during non-fasting times are unhealthy; a nutritionist/ dietician should monitor closely • Does not necessarily emphasize healthful meal quality • May not be suitable for patients with eating disorders, such as bulimia or binge-eating disorder • The risk of hypoglycemia is elevated in individuals with diabetes mellitus who do not properly modulate their hypoglycemic pharmacotherapy, such as with insulin and sulfonylureas • May not be sustainable over a lifetime for a chronic condition such as obesity • Most long-term evidence about eff icacy, health benef its, and safety is primarily obtained f rom animal studies • Prolonged fasting, as opposed to intermittent fasting, may contribute to the development of gout, urate nephrolithiasis, postural hypotension, and cardiac dysrhythmias • May not improve metabolic health in individuals with signif icant insulin resistance if overall dietary quality and energy balance during non fasting periods remains poor.

Articles in this issue

Archives of this issue

view archives of OMA Guidelines Bundle - Obesity Nutrition and Activity 2026